Technical Analysis for MYMD - MyMD Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | -0.92% | |
Crossed Above 20 DMA | Bullish | -0.92% | |
Wide Bands | Range Expansion | -0.92% | |
Fell Below 20 DMA | Bearish | -0.55% | |
Fell Below 50 DMA | Bearish | -0.55% | |
Wide Bands | Range Expansion | -0.55% | |
Overbought Stochastic | Strength | -0.55% | |
Gapped Down | Weakness | -0.55% | |
Wide Bands | Range Expansion | -11.60% | |
Overbought Stochastic | Strength | -11.60% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 3 hours ago |
Down 1% | about 4 hours ago |
Fell Below 20 DMA | about 4 hours ago |
Rose Above 50 DMA | 1 day ago |
Rose Above 20 DMA | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
MyMD Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the development of drug products in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety, and sleep disorders. It commercializes MYMD-1, a novel therapeutic to impact conditions related to immunometabolic dysregulation; and SUPERA-1R, a synthetic cannabidiol that offers bioavailability and potency than botanicals. The company was incorporated in 2014 and is based in Tampa, Florida.
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Pharmaceutical Immunology Health Sciences Autoimmune Disease Medication Health Care Cannabis Disorders Euphoriants Chronic Pain Entheogens Autoimmunity Drug Products Cannabidiol Age Related Diseases Appetite Stimulants
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Pharmaceutical Immunology Health Sciences Autoimmune Disease Medication Health Care Cannabis Disorders Euphoriants Chronic Pain Entheogens Autoimmunity Drug Products Cannabidiol Age Related Diseases Appetite Stimulants
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 70.5 |
52 Week Low | 2.0 |
Average Volume | 268,118 |
200-Day Moving Average | 12.09 |
50-Day Moving Average | 2.78 |
20-Day Moving Average | 2.72 |
10-Day Moving Average | 2.99 |
Average True Range | 0.26 |
RSI (14) | 47.92 |
ADX | 33.02 |
+DI | 29.32 |
-DI | 20.76 |
Chandelier Exit (Long, 3 ATRs) | 2.72 |
Chandelier Exit (Short, 3 ATRs) | 2.78 |
Upper Bollinger Bands | 3.40 |
Lower Bollinger Band | 2.05 |
Percent B (%b) | 0.51 |
BandWidth | 49.76 |
MACD Line | 0.07 |
MACD Signal Line | 0.05 |
MACD Histogram | 0.0262 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.10 | ||||
Resistance 3 (R3) | 3.12 | 3.02 | 3.04 | ||
Resistance 2 (R2) | 3.02 | 2.92 | 3.01 | 3.02 | |
Resistance 1 (R1) | 2.87 | 2.86 | 2.94 | 2.85 | 3.00 |
Pivot Point | 2.77 | 2.77 | 2.80 | 2.76 | 2.77 |
Support 1 (S1) | 2.62 | 2.67 | 2.70 | 2.61 | 2.46 |
Support 2 (S2) | 2.52 | 2.61 | 2.51 | 2.44 | |
Support 3 (S3) | 2.37 | 2.52 | 2.42 | ||
Support 4 (S4) | 2.36 |